Wyeth-Ayerst to reduce U.S. price of Norplant implants, but not until December 1995. Family planners outraged.
D000288:Administrative Personnel; D000569:Americas; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003365:Costs and Cost Analysis; D003431:Cross-Cultural Comparison; D003695:Delivery of Health Care; D019049:Developed Countries; D004467:Economics; D004493:Education; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006262:Health; D006282:Health Personnel; D016912:Levonorgestrel; D008389:Marketing of Health Services; D009656:North America; D010820:Physicians; D017149:Private Sector; D017150:Public Sector; D012736:Sex Education; D014481:United States
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D016912:Levonorgestrel
Administrative Personnel; Americas; Comparative Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Implants; Contraceptive Methods; Critique; Cross-cultural Comparisons; Delivery Of Health Care; Developed Countries; Economic Factors; Education; Family Planning; Family Planning Training; Health; Health Personnel; Levonorgestrel; Macroeconomic Factors; Marketing; North America; Northern America; Physicians; Policymakers; Pricing; Private Sector; Public Sector; Studies; Training Programs; United States